NHS

News

NICE backs consolidation use of Blincyto in leukaemia

NICE backs NHS use of Amgen's Blincyto for the consolidation phase of treatment for some patients with acute lymphoblastic leukaemia.

News

NICE changes its mind on BMS' lymphoma cell therapy

Around 600 people with various types of B-cell lymphoma will be eligible for treatment with BMS' CAR-T therapy Breyanzi under new NICE guidance.

News

UCB's non-cannabis drug for severe epilepsy gets NHS okay

Around 1,400 patients with Lennox-Gastaut Syndrome will be eligible for NHS treatment with UCB's Fintepla after a NICE recommendation.

Market Access

NICE contribution to the cost per QALY threshold debate?

Leela Barham sets out some wider context to the latest blog from NICE on the cost-effectiveness threshold used by the agency and highlights the opportunity for stakeholders to build their c

News

Liva buys Momenta to bolster digital health platform

Liva Healthcare has acquired Momenta to create one of the largest providers of digital healthy lifestyle services to the NHS in England.

News

Woman attended by female radiologist having a mammogram

NHS trial puts AI for breast cancer screening under scrutiny

Nearly 700,000 women will be recruited into an NHS trial of AI tools for breast cancer screening, in the hope of relieving pressure on radiologists.

NICE backs consolidation use of Blincyto in leukaemia

NICE changes its mind on BMS' lymphoma cell therapy

UCB's non-cannabis drug for severe epilepsy gets NHS okay

NICE contribution to the cost per QALY threshold debate?

Liva buys Momenta to bolster digital health platform

NHS trial puts AI for breast cancer screening under scrutiny

Threat of Trump's pharma tariffs looms again

Using AI-driven synthetic personas to take your insights fur...

NHS

Editor's Picks